Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.41 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 9/20 | 0.40 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.40 |
| ▸ | FYN | P06241 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.40 |
| ▸ | AHR | P35869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29400184 | 1.00 | TLR9 (0.47) | TLR9ALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL29634180 | 1.00 | TLR9 (0.47) | TLR9ALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL22399176 | 0.92 | TLR9 (0.48) | TLR9ALDH1A1KDM4EKMT2AHSP90AA1 | |
| Acetonitrile SCHEMBL28436643 | 0.92 | ALDH1A1 (0.41) | TLR9ALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL30570724 | 0.86 | CYP1A2 (0.46) | TLR9ALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL1552172 | 0.86 | CYP1A2 (0.46) | TLR9ALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL721959 | 0.84 | CYP1A2 (0.47) | TLR9ALDH1A1KDM4EKMT2AHPGD | |
| SCHEMBL21972845 | 0.82 | TLR9 (0.39) | TLR9ALDH1A1KMT2ATDP1HSP90AA1 | |
| SCHEMBL3263559 | 0.80 | ALDH1A1 (0.45) | ALDH1A1KDM4EKMT2AHPGDHSD17B10 | |
| SCHEMBL19511453 | 0.78 | TLR9 (0.62) | TLR9ALDH1A1KDM4EKMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 943 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4698675-A1 | ELECTRONIC BIOSENSORS HAVING METAL-NONMETAL COMPOUND SEMICONDUCTOR NANOBRIDGE ARRAY | SemiconBio Inc. (US) | 2026-02-25 | — | — | EP | claimed |
| US-20250241113-A1 | FILM, OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE | TCL TECHNOLOGY GROUP CORPORATION (CN) | 2025-07-24 | — | — | US | claimed |
| WO-2025068791-A1 | NEW FERRITIN-BASED DELIVERY SYSTEM FOR BODIPY MOLECULES | DISRUPTIVE TECHNOLOGICAL ADVANCES IN LIFE SCIENCE S.R.L.- SOCIETÀ BENEFIT, IN FORMA ABBREVIATA, D-TAILS S.R.L. SB (IT) | 2025-04-03 | — | — | WO | claimed |
| US-12220420-B2 | Combination therapy for cancer treatment | GALERA LABS, LLC (US) | 2025-02-11 | — | — | US | claimed |
| WO-2024220344-A1 | ELECTRONIC BIOSENSORS HAVING METAL-NONMETAL COMPOUND SEMICONDUCTOR NANOBRIDGE ARRAY | ROSWELL ME, INC. (US) | 2024-10-24 | — | — | WO | claimed |
| CN-117647913-A | Negative photosensitive resin composition, application thereof, hardening film, preparation thereof and electronic device | 深圳市道尔顿电子材料股份有限公司 | 2024-03-05 | — | — | CN | claimed |
| CN-117143496-B | Water-based epoxy anti-corrosion coating liquid and preparation method thereof | 江苏零界科技集团有限公司 | 2023-12-29 | — | — | CN | claimed |
| CN-117143496-A | Water-based epoxy anti-corrosion coating liquid and preparation method thereof | 江苏零界科技集团有限公司 | 2023-12-01 | — | — | CN | claimed |
| CN-115262231-B | Self-repairing self-cleaning electromagnetic shielding fabric coating and preparation method and application thereof | 江南大学 | 2023-11-21 | — | — | CN | claimed |
| EP-3632941-B1 | RESIN COMPOSITION | CUBICURE GMBH (AT) | 2023-08-23 | — | — | EP | claimed |
| WO-2005054854-A1 | FLUORESCENCE POLARIZATION INSTRUMENTS AND METHODS FOR DETECTION OF EXPOSURE TO BIOLOGICAL MATERIALS BY FLUORESCENCE POLARIZATION IMMUNOASSAY OF SALIVA, ORAL OR BODILY FLUIDS | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY NAVAL MEDICAL RESEARCH CENTER (US) | 2005-06-16 | — | — | WO | claimed |
| US-20050095601-A1 | Fluorescence polarization instruments and methods for detection of exposure to biological materials by fluorescence polarization immunoassay of saliva, oral or bodily fluids | NAVY, UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE | 2005-05-05 | — | — | US | claimed |
| WO-2005003376-A2 | ANTHRAX ANTIGEN VACCINE CULTURES BY FLUORESCENCE POLARIZATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY NAVAL MEDICAL RESEARCH CENTER, CODE 00L (US) | 2005-01-13 | — | — | WO | claimed |
| US-20040235075-A1 | Rapid immunoassay of anthrax protective antigen in vaccine cultures and bodily fluids by fluorescence polarization | CULLUM MALFORD E (US) | 2004-11-25 | — | — | US | claimed |
| EP-1335984-A1 | DETERMINATION OF HYDROPHOBIC COENZYME A ESTERS AND OTHER LIPIDS USING A BIOSENSOR COMPRISING A MODIFIED COENZYME A- AND ACYL-COA BINDING PROTEIN (ACBP) | Biosensor APS (DK) | 2003-08-20 | — | — | EP | claimed |
| US-20020142347-A1 | Biosensor | BIOSENSOR APS (DK) | 2002-10-03 | — | — | US | claimed |
| WO-2002061096-A1 | DETERMINATION OF HYDROPHOBIC COENZYME A ESTERS AND OTHER LIPIDS USING A BIOSENS OR COMPRISING A MODIFIED COENZYME A- AND ACYL- BINDING PROTEIN (ACBP) | BIOSENSOR APS (DK) | 2002-08-08 | — | — | WO | claimed |
| US-4942136-A | Method for production of fluorescence-labeled Fab' | AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 1990-07-17 | — | — | US | claimed |
| US-4537718-A | GLUTATHIONE JOINED BY LINKAGE GROUPS TO A SECTROSCOPIC REPORTER | COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 1985-08-27 | — | — | US | claimed |
| US-4207075-A | Rabbit immunoglobulin-N-(3-pyrene)-maleimide conjugate for fluorescent immunoassay | LIBURDY ROBERT P | 1980-06-10 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12220420-B2 | Combination therapy for cancer treatment | TXNRD1, TXNRD2, GPX1 | TLR9 4653/4885ALDH1A1 153/4885KDM4E 4249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.